Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection

Lookup NU author(s): Professor Christopher WardORCiD, Dr Malcolm BrodlieORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

BACKGROUND:Interleukin (IL)-22 is a critical mediator of mucosal immunity and tissue regeneration, protecting against a number of respiratory pathogens. Whether IL-22 confers protection against chronic Pseudomonas aeruginosa (PA) infection in cystic fibrosis (CF) is unknown.METHODS:Explanted CF lungs were examined for IL-22 production and immune-localization. A murine model of persistent pulmonary PA infection was used to examine production of IL-22 following infective challenge. The role of IL-22 was examined using IL-22 knockout (KO) animals.RESULTS:IL-22 is produced within the adult CF lung and localizes to the airway epithelium. IL-22 is produced by murine pulmonary lymph node cells following lung infection. The absence of IL-22 resulted in no significant difference in acute mortality, bacterial burden, chronic infection rates, histological changes or neutrophilic inflammation in the chronic PA infection model. However, IL-22 KO animals lost less weight following infection.CONCLUSION:IL-22 is produced in the CF lung and in response to PA infection yet is dispensable in protection against chronic pulmonary P. aeruginosa infection in a murine model. However, we identified a novel role for the cytokine in promoting infection-related weight-loss, a significant prognostic factor in the CF population.


Publication metadata

Author(s): Bayes HK, Ritchie ND, Ward C, Corris PA, Brodlie M, Evans TJ

Publication type: Article

Publication status: Published

Journal: Journal of Cystic Fibrosis

Year: 2016

Volume: 15

Issue: 6

Pages: 759–768

Print publication date: 01/11/2016

Online publication date: 01/07/2016

Acceptance date: 15/06/2016

Date deposited: 26/07/2016

ISSN (print): 1569-1993

ISSN (electronic): 1873-5010

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/j.jcf.2016.06.008

DOI: 10.1016/j.jcf.2016.06.008

PubMed id: 27375092


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
094779Wellcome Trust

Share